MRK - Merck & Co., Inc.
After hours:
Chart Events
MACD
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 112.30 |
| Open | 112.00 |
| Bid | 111.00 x 800 |
| Ask | 117.50 x 900 |
| Day's Range | 110.65 - 113.19 |
| 52 Week Range | 83.05 - 119.65 |
| Volume | |
| Avg. Volume | 7,384,817 |
| Market Cap | 281.833B |
| Beta (5Y Monthly) | 0.36 |
| PE Ratio (TTM) | 21.69 |
| EPS (TTM) | 5.12 |
| Earnings Date | Aug 01, 2023 |
| Forward Dividend & Yield | 2.92 (2.63%) |
| Ex-Dividend Date | Jun 14, 2023 |
| 1y Target Est | 124.21 |
Fair Value
Related Research
Business WireKEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
RAHWAY, N.J. & NUTLEY, N.J., May 25, 2023--KEYTRUDA® Plus LENVIMA® Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced RCC
ZacksInvestors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Insider Monkey14 Best Biotech Stocks To Buy According To Hedge Funds
In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds. For more stocks, head on over to 5 Best Biotech Stocks To Buy According To Hedge Funds. Biotechnology is one of the hottest sectors these days. A handful of industries, such as space exploration, artificial intelligence, […]
Insider Monkey14 Best Healthcare Dividend Stocks to Buy
In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and […]
InvestorPlace7 Stocks That Could Be the Next $2 Trillion-Dollar Companies
As someone who has been writing about stocks professionally for 18 years, I remember when Microsoft (NASDAQ:MSFT), Amazon (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) were the first companies with $1 trillion market capitalizations. There was a great deal of fascination with the milestones at the time. Subsequently, both overcame the $2 trillion mark, and Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) has also joined the $1 trillion club. I guess it’s natural that the first companies to cross that huge $1 trilli
Business WireMerck Announces Third-Quarter 2023 Dividend
RAHWAY, N.J., May 23, 2023--Merck Announces Third-Quarter 2023 Dividend
The Wall Street JournalFed Rate Increases Hit Small Businesses the Hardest
For companies that need to borrow money these days, it pays to be big. The Federal Reserve’s rate-raising campaign has put a notable crimp in financing for companies with smaller payrolls and valuations. The average rate for a loan from the U.S. Small Business Administration, which historically costs less than a bank loan, has reached double-digits, driving many small firms to borrow less.
InvestorPlace3 Undervalued Pharma Stocks to Buy for High Total Returns
Throughout financial history, equity markets have navigated bull and bear cycles. The same holds true for various sectors. After an extended bull market, there tends to be a price and time correction phase in various sectors. One secret to successful investing is to identify sectors that have been depressed for an extended period. Stocks in this sector tend to be undervalued, and once sentiments reverse, the rally can be massive. My focus in this column is on undervalued pharma stocks to buy. To
Insider Monkey25 Most Prescribed Medication in the World
In this article, we will be taking a look at the 25 most prescribed medication in the world. To skip our detailed analysis, you can go directly to see the 10 most prescribed medication in the world. The advancements that the medical field has accomplished over the past century, and especially in recent decades, has […]
InvestorPlaceShhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs
Everyone seems to be talking about semiconductors, artificial intelligence (AI) and mega-cap tech. However, no one seems to be talking about healthcare stocks to buy. That said, I get it. Semiconductor stocks and AI stocks are the exciting plays in the market, while mega-cap tech is powering the S&P 500 higher. In fact, just a handful of names have driven almost all of the year-to-date gains in the index.InvestorPlace - Stock Market News, Stock Advice & Trading Tips While these stocks are domina
Yahoo Finance VideoFed, labor market concerns showing 'some dents in the armor of the consumer': Strategist
Hennion & Walsh CIO Kevin Mahn joins Yahoo Finance Live to discuss the state of the consumer amid retail earnings, Target Q1 earnings, Walmart earnings preview, Fed rate hikes, inflation, and the impact on consumer spending.
BloombergDrugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
(Bloomberg) -- European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma is closely watching.Most Read from BloombergHere’s How Much Wealth You Need to Join the Richest 1% GloballyMercedes Sets Out to Make Sexy Vans With Yacht-Like InteriorsJPMorgan Asset Says Markets Are Right to Bet on US Rate CutsDebt-Limit Talks to Intensify as Biden Set to Depart for JapanSeveral major drugmakers keen to expand in immunology have been studying the $23 bi
Insider MonkeyBillionaire Ken Fisher’s Top 15 Dividend Stock Picks
In this article, we discuss billionaire Ken Fisher’s top 15 dividend stock picks. You can skip our detailed analysis of Fisher’s hedge fund and his investment philosophy, and go directly to read Billionaire Ken Fisher’s Top 5 Dividend Stock Picks. Ken Fisher’s Fisher Asset Management is one of the most prominent hedge funds in America. […]
Business WireMerck to Present Extensive New Research Demonstrating Significant Progress in the Treatment of Certain Earlier Stage Cancers and in Advancing Broad Oncology Pipeline at 2023 ASCO Annual Meeting
RAHWAY, N.J., May 15, 2023--Merck ASCO Curtain Raiser
Insider Monkey10 “Great” Earnings Reports Jim Cramer is Talking About
In this article, we will take a look at the 10 “great” earnings reports that Jim Cramer is talking about. If you want to explore similar stocks that Jim Cramer likes, you can also take a look at 5 “Great” Earnings Reports Jim Cramer is Talking About. “The Fed is Either Done Tightening, or Almost […]
ZacksThe Zacks Analyst Blog Highlights UnitedHealth Group, Merck, Texas Instruments, The TJX Companies and Johnson Controls International
UnitedHealth Group, Merck, Texas Instruments, The TJX Companies and Johnson Controls International are part of the Zacks top Analyst Blog.
ZacksTop Research Reports for UnitedHealth Group, Merck & Texas Instruments
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Merck & Co., Inc. (MRK) and Texas Instruments Incorporated (TXN).
Yahoo Finance UKUS stocks and FTSE 100 lower as BoE hikes rates again
Investors are gearing up for an announcement on UK interest rates which is due at noon.
Insider Monkey15 Biggest Immunotherapy Companies in the World
In this article, we will take a look at the 15 biggest immunotherapy companies in the world. If you want to see more companies in this selection, go to the 5 Biggest Immunotherapy Companies in the World. The immunotherapy industry is a rapidly growing field that is focused on developing treatments that harness the power […]
ACCESSWIREMerck Announces Global Grants Program To Improve Access to Quality Health Care in Underserved Communities
To support the work of nonprofits dedicated to improving the well-being of underserved populations in communities around the world, Merck (NYSE:MRK), known as MSD outside of the United States and Canada, has announced a new global grants program, Solutions for Healthy Communities (SHC).
ZacksModerna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
Moderna (MRNA) beats expectations for both earnings and sales. The company posts higher-than-expected product sales from its COVID vaccine
ZacksHere is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
- Reuters
Moderna beats COVID vaccine sales expectations as deferred revenue rolls in
Moderna Inc on Thursday reported stronger-than-expected sales of $1.9 billion for its COVID-19 vaccine in the first quarter, driven by a surge of revenue deferred from 2022, but left its 2023 sales expectations unchanged. The vaccine maker posted a profit of 19 cents per share, compared with analyst expectations for a loss of $1.77 per share, in part because sales were higher than expected. Moderna said it continued to expect COVID vaccine sales of $5 billion for the year based on advance purchase agreements.
BenzingaInsurers Can't Use War Argument: Court Rules in Favor of Merck in $1.4 Billion Cyberattack Coverage Case
A New Jersey appellate court ruled that a group of insurers can’t use war as an argument to deny Merck & Co Inc (NYSE: MRK) coverage from the $1.4 billion cyberattack that happened in 2017. The court said the insurers must help the pharma giant cover losses from the cyber attack that the U.S. blamed on Russia. New Jersey appellate division judges said that the NotPetya cyberattack didn’t involve military action and can’t be excluded from coverage under a warlike-act exclusion. “The exclusion of